HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 169-180 of 1,979
Drug study icon
CompletedNCT00723450

Lamictal as Add-on Treatment for Bipolarity type I in Pediatric Patients

Official study title

The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
GlaxoSmithKline
Drug study icon
CompletedNCT01737268

Long-term Study of FK949E in Elderly Bipolarity Patients

What is this study about?

Researchers studied FK949E to find out how it affected depression symptoms in older adults with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Chiba
BipolarityMedication studyAges 65+
Countries
Japan
Sponsor
Astellas Pharma Inc
Behavioral study icon
Active Not RecruitingNCT04447807

Metacognitive Training With Bipolarity Patients.

Official study title

Rehabilitating Social Cognition: A Randomized Control Study Using Metacognitive Training in a Group Format With Bipolar Disorder Patients.

This study is no longer accepting new participants.

In São Paulo
BipolarityBehavioural studyAges 18–60
Countries
Brazil
Sponsor
University of Sao Paulo
Behavioral study icon
CompletedNCT03507647

Mindfulness Based Cognitive Therapy for Bipolarity

Official study title

Mindfulness Based Cognitive Therapy for Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Nijmegen
BipolarityBehavioural studyAges 18+
Countries
Netherlands
Sponsor
Radboud University Medical Center
Behavioral study icon
CompletedNCT07297056

Mindfulness Psychoeducation for Bipolarity

Official study title

The Effect of Mindfulness-Based Psychoeducation Programme on Mindfulness, Self-Compassion and Forgiveness Tendencies of Patients With Bipolar Disorder: A Randomised Controlled Trial

This study has finished and is no longer accepting participants.

In Aydin
BipolarityInterventional studyAges 18–65
Countries
Türkiye
Sponsor
Ömer USLU
Behavioral study icon
CompletedNCT01764035

Mindfulness Therapy on Disrupted Sleep in Bipolarity

Official study title

The Effects of Mindfulness on Disrupted Sleep in Bipolar Disorder

This study has finished and is no longer accepting participants.

In Boston
BipolarityBehavioural studyAges 18–65
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Other study type icon
CompletedNCT01770704

Observation Study of the Clinical Management of Bipolarity

Official study title

Chinese Observation Study of the Clinical Management of Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Beijing
BipolarityObservational studyAges 18+
Countries
China
Sponsor
AstraZeneca
Other study type icon
CompletedNCT06256367

Cariprazine Capsules to Assess Change for Bipolarity

Official study title

Cariprazine Real-world Use in Bipolar I Disorder: Effectiveness, Functioning, Quality of Life, and Tolerability

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
BipolarityObservational studyAges 18+
Countries
United States, Canada
Sponsor
AbbVie
Drug study icon
CompletedNCT01710709

Effectiveness of intramuscular Formulation of Aripiprazole in Bipolarity

What is this study about?

This study evaluated the effectiveness of Aripiprazole for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
BipolarityMedication studyAges 18–65
Countries
United States, France, Canada, + 7 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.